Navigation Links
Clinical Chemistry Market Report & Forecast (2012 - 2015): Global Analysis
Date:7/5/2012

NEW YORK, July 5, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis http://www.reportlinker.com/p0923602/Clinical-Chemistry-Market-Report--Forecast-2012-–-2015-Global-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics 

Clinical Chemistry Market Overview

Valued at more than US$ 9 Billion in 2011, Clinical Chemistry market is likely to grow moderately from 2012 to 2015. In Clinical Chemistry Tests segment: Toxicology, Hemoglobin and Cholesterol testing contributed more than 40% of market revenues in 2011, and in future also they are likely to dominate the market till 2015. Faecal Occult Blood testing market, Cardiac Enzyme testing market and Prothrombin Time/International Normalized Ratio (PT/INR) testing market all these three testing markets are expected to grow with double digit CAGR from 2012 – 1015.

In countries analysis segment, United States and Europe together holds more than 85% market share in 2011. But by 2015 China is expected to nearly double its market revenue from 2011; thus reducing the market share of Europe in worldwide Clinical Chemistry market by 2015. Brazil Clinical Chemistry market is bigger than India but it is expected to grow with a CAGR of single digit compared to double digit of India from 2012 – 2015. In the coming years, the Clinical Chemistry market will undertake important change. These changes will be caused by the convergenc
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... 2015 Perrigo Company plc ("Perrigo") (NYSE: ... ("Mylan") (NASDAQ: MYL ) shareholder vote regarding its ... views of Mylan,s offer to Perrigo shareholders have always ... Board,s careful reflection of the value available to Perrigo ... that Mylan has allowed its shareholders to consider," said ...
(Date:8/28/2015)... Aug. 28, 2015 , Joint ... Ra from Biostar , Published in ,Stem Cells ... of lifespan through multiple IV administration of Adipose-derived MSC ... life expectancy found , Commercialization within 5 years ... the possibility that adult mesenchymal stem cells (MSCs) may ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ... the new Global Communications Director for InHealth Media. Mr. Spector comes with ... last 16 years doing on-air television, producing shows, on air-radio and media relations. ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, ... ... today that Executive Vice President Jeff Fernandez will lead the expansion of global ... of cosmeceutical and skin care experience having spent the last 25 years working ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris Bustamante ... Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado ... its reach and impact through innovative technologies and strategies. , “I am very proud ...
(Date:8/29/2015)... ... 2015 , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of ... will present an educational program titled “Asbestos and Your Health.” , The two and ... open at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible by ... of patients, according to a newly published report. Surviving Mesothelioma has more on ... , The authors of the new paper focus on several types of ...
Breaking Medicine News(10 mins):Health News:InHealth Media Appoints New Global Communications Director 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2
... Louisville Health Sciences Center faculty and students made an ... four regions of Kentucky served by UofL Area Health ... donated services valued at $5,606,599 while their students spent ... in the four regions. These regions encompass 56 counties ...
... HealthDay Reporter , WEDNESDAY, Jan. 11 (HealthDay News) -- Americans ... life expectancy going from 78.6 years in 2009 to 78.7 ... a percent between 2009 and 2010, and hit the lowest ... the latest set of data from the U.S. Centers for ...
... , WEDNESDAY, Jan. 11 (HealthDay News) -- The first major gene ... been identified by scientists. Men who inherit the mutation in ... of developing prostate cancer, according to the study in the Jan. ... The HOXB13 gene plays an important role in the development ...
... WEDNESDAY, Jan. 11 (HealthDay News) -- A new type of ... to help re-educate rogue immune system cells, which allows cells ... The treatment, which combines a patient,s immune system cells with ... people with long-standing diabetes who were believed to have no ...
... News) -- A small study that offers new insight into ... effective treatments for people with drinking problems. Researchers used ... alcohol in the brains of 13 heavy drinkers and a ... In all of the participants, drinking alcohol triggered the ...
... have discovered that a subtype of leukemia characterized by ... distinctly different from a seemingly similar leukemia associated with ... Jude Children,s Research Hospital Washington University Pediatric Cancer ... treating patients with this more aggressive cancer. ...
Cached Medicine News:Health News:UofL centers have economic impact in excess of $5.7 million 2Health News:UofL centers have economic impact in excess of $5.7 million 3Health News:Americans Living Longer, Report Finds 2Health News:Americans Living Longer, Report Finds 3Health News:Scientists Identify Inherited Prostate Cancer Gene 2Health News:Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes 2Health News:Novel Stem Cell Treatment May Hold Promise for Type 1 Diabetes 3Health News:Alcohol Targets Brain 'Reward Centers' in Heavy Drinkers 2Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 2Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 3Health News:Cancer sequencing project identifies potential approaches to combat aggressive leukemia 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: